Wen Jiang: Translational Challenges and Opportunities in mRNA Cancer Vaccines
Wen Jiang/LinkedIn

Wen Jiang: Translational Challenges and Opportunities in mRNA Cancer Vaccines

Wen Jiang, Physician Scientist, Engineer, Entrepreneur, Co-Founder at MusiQ Bio, shared on LinkedIn:

“Excited to share that our latest paper is now online in AACR Journals Cancer Discovery:

Title: Translational Challenges and Opportunities in mRNA Cancer Vaccines

Authors: Seong Dong Jeong, Benjamin R. Schrank, James J. Mancuso, Betty Y.S. Kim, Wen Jiang, Padmanee Sharma

Read the Full Article

mRNA cancer vaccines are entering an exciting phase of clinical translation. In this article, we discuss the key scientific, engineering, and clinical challenges that must be addressed to move these technologies from promising early studies toward broadly effective cancer therapies.

Congratulations and thank you to all of our collaborators Betty Kim, Pam Sharma who contributed to this work!”

You may also be interested in: ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy

Wen Jiang